4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole has been researched along with dihydroalprenolol in 1 studies
| Studies (4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole) | Trials (4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole) | Recent Studies (post-2010) (4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole) | Studies (dihydroalprenolol) | Trials (dihydroalprenolol) | Recent Studies (post-2010) (dihydroalprenolol) |
|---|---|---|---|---|---|
| 50 | 0 | 3 | 1,240 | 2 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gether, U; Kobilka, BK; Lin, S | 1 |
1 other study(ies) available for 4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole and dihydroalprenolol
| Article | Year |
|---|---|
Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cell Line; Cysteine; Dihydroalprenolol; Fluorescent Dyes; Histidine; Humans; Isoproterenol; Kinetics; Ligands; Models, Structural; Oxadiazoles; Protein Conformation; Receptors, Adrenergic, beta-2; Recombinant Proteins; Sensitivity and Specificity; Sequence Tagged Sites; Spectrometry, Fluorescence; Spodoptera; Time Factors; Transfection | 1995 |